COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,281 Articles (22,759 medRxiv, 8,522 bioRxiv)

Most recent first Previous |  Page 1660: Articles 16591-16600  | Next

Performance of early warning signals for disease emergence: a case study on COVID-19 data
Proverbio, D., Kemp, F., Magni, S., Goncalves, J.
10.1101/2021.03.30.21254631 — Posted: 2021-03-31
Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of a nationwide serosurvey in the Netherlands
McDonald, S. A., Miura, F., Vos, E. R. A., van Boven, M., de Melker, H. E., van der Klis, F. R. M., van Binnendijk, R. S., den Hartog, G., Wallinga, J.
10.1101/2021.03.29.21254334 — Posted: 2021-03-31
Validity of markers and indexes of systemic inflammation in predicting mortality in COVID 19 infection : A hospital based cross sectional study
Baburao, A., Shamsunder, s., Das, R.
10.1101/2021.03.30.21254635 — Posted: 2021-03-31
Prevalence of anti-SARS-CoV-2 antibodies in Poznan, Poland, after the first wave of the COVID-19 pandemic
Lorent, D., Nowak, R., Roxo, C., Lenartowicz, E., Makarewicz, A., Zaremba, B., Nowak, S., Kuszel, L., Stefaniak, J., Kierzek, R., Zmora, P.
10.1101/2021.03.29.21254544 — Posted: 2021-03-31
Saliva as a Reliable Sample for COVID-19 Diagnosis in Paediatric Patients
Felix, A. C., De Paula, A. V., Ribeiro, A. C., Inemami, M., Costa, A. A., Leal, C. O. D., Figueiredo, W. M., Sarmento, D. J. S., Sassaki, T. A., Pannuti, C. S., Braz-Silva, P. H., Romano, C. M.
10.1101/2021.03.29.21254566 — Posted: 2021-03-31
COVID-19 vaccine impact on rates of SARS-CoV-2 cases and post vaccination strain sequences among healthcare workers at an urban academic medical center: a prospective cohort study
Bouton, T. C., Lodi, S., Turcinovic, J., Weber, S. E., Quinn, E., Korn, C., Steiner, J., Schechter-Perkins, E. M., Duffy, E., Ragan, E. J., Taylor, B. P., Schaeffer, B., Miller, N., Davidoff, R., Hanage, W. P., Connor, J., Pierre, C., Jacobson, K. R.
10.1101/2021.03.30.21254655 — Posted: 2021-03-31
Improved performance of saliva for the detection of the B.1.351 variant in South Africa
Chu, C. Y., Marais, G., Opperman, C., Doolabh, D., Iranzadeh, A., Marais, C., Cox, H., Williamson, C., Hardie, D. R., Brink, A.
10.1101/2021.03.29.21254563 — Posted: 2021-03-31
Impact of COVID-19 pandemic on rare diseases- A case study on thalassaemia patients in Bangladesh
Hossain, M. S., Runa, F., Mosabbir, A. A.
10.1101/2021.03.29.21254589 — Posted: 2021-03-31
Healthcare workers' perceptions and attitudes towards the UK COVID-19 vaccination programme
Manby, L., Dowrick, A., Karia, A., Maio, L., Buck, C., Singleton, G., Lewis-Jackson, S., Uddin, I., Vanderslott, S., Martin, S., Vindrola-Padros, C.
10.1101/2021.03.30.21254459 — Posted: 2021-03-31
Psychological distress and resilience in a sample of Adolescents and Young Adults with cancer during the COVID-19 pandemic
Jacobson, C., Rebecca Mulholland, R., Baker, L., Glazer, D., Betts, E., Brown, L., Elders, V., Ogundiran, O., Carr, R., Hudson, L. D.
10.1101/2021.03.29.21254529 — Posted: 2021-03-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).